Risk of idiopathic cerebral haemorrhage in women on oral contraceptives with differing progestagen components.
The risk of idiopathic cerebral haemorrhage in users of third-generation oral contraceptives compared with that of users of second-generation oral contraceptives was evaluated using data from the General Practice Research Database. We found no increased risk for third-generation oral contraceptives, compared with second-generation oral contraceptives.
Jick
S S
SS
Myers
M W
MW
Jick
H
H
D000328:Adult; D002543:Cerebral Hemorrhage / Q000139:chemically induced*; D003280:Contraceptives, Oral, Synthetic / Q000009:adverse effects*; D017135:Desogestrel / Q000009:adverse effects; D005260:Female; D006801:Humans; D016912:Levonorgestrel / Q000009:adverse effects; D008875:Middle Aged; D009652:Norpregnenes / Q000009:adverse effects; D045167:Progesterone Congeners / Q000009:adverse effects*; D012307:Risk Factors
D003280:Contraceptives, Oral, Synthetic; D009652:Norpregnenes; D045167:Progesterone Congeners; C033273:Gestodene; D016912:Levonorgestrel; D017135:Desogestrel